Sertraline treatment of panic disorder: results of a long-term study (Q34519618)

2 August 2017

title

Sertraline treatment of panic disorder: results of a long-term study (English)

1 reference

2 August 2017

1 reference

1 reference

Rapaport MH

1

1 reference

2 August 2017

Wolkow R

2

1 reference

2 August 2017

Rubin A

3

1 reference

2 August 2017

Hackett E

4

1 reference

2 August 2017

Pollack M

5

1 reference

2 August 2017

Ota KY

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Acta Psychiatrica Scandinavica

2 August 2017

published in

1 reference

2 August 2017

volume

104

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

289-298

1 reference

Outcome of panic disorder. Relationship to diagnostic subtypes and comorbidity

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

The Galway Study of Panic Disorder. III. Outcome at 5 to 6 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

Outcome of panic and depression in a seven-year follow-up: results of the Zurich study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

Quality of life in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

Panic disorder and quality of life: variables predictive of functional impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

Long-term outcome of panic disorder treatment. A review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

Withdrawal phenomena associated with antidepressant and antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

Sertraline in the treatment of panic disorder: a double-blind multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

The assessment of anxiety states by rating

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

Multicenter collaborative panic disorder severity scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

Long-term Therapeutic Use of Benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

Long-term Therapeutic Use of Benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

Comparison of descriptive variables for symptomatic volunteers and clinical patients with anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

Panic attacks in the community. Social morbidity and health care utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00263.X

10.1034/J.1600-0447.2001.00263.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference